Nasdaq
华尔街日报PHOENIX, Dec. 16, 2025 /PRNewswire/ -- Aces Diagnostics Inc., a biotechnology company dedicated to delivering accurate and accessible diagnostics for Lyme disease, announced significant progress toward commercialization of its flagship LymeSeek™ test through new development partnerships with Protavio and Repado.
Read more at prnewswire.comAces Diagnostics Announces Key Development Partnerships for Novel LymeSeek™ Test
Barchart·12/16/2025 07:46:00
语音播报
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.